Hypertension Clinical Trials in London, Ontario
5 recruitingLondon, Ontario, Canada
Showing 1–5 of 5 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 2
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
Pulmonary Hypertension
Pfizer36 enrolled36 locationsNCT07073820
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled753 locationsNCT06742723
Recruiting
Phase 3
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Pulmonary Hypertension
Tenax Therapeutics, Inc.230 enrolled44 locationsNCT05983250
Recruiting
Phase 2
Feasibility Trial for a Right Ventricular Failure Platform Trial
Pulmonary HypertensionRight Ventricular DysfunctionRight Heart Failure
University of Alberta30 enrolled5 locationsNCT06570473